Free Trial

10 Best Penny Stocks to Buy Now - 5 of 10

 
 

Invivyd (NASDAQ:IVVD)

Number of Upgrades from Top-Ranked Analysts
4 (in the last 90 days)
Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$11.33 (1,400.9% Upside)

About Invivyd

Invivyd logoInvivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/30/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
10/29/2024HC WainwrightReiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
9/3/2024HC WainwrightReiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
8/27/2024HC WainwrightReiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
5/24/2024HC WainwrightReiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
5/14/2024HC WainwrightReiterated RatingBuy ➝ Buy$15.00
4/5/2024GuggenheimUpgradeNeutral ➝ Buy$9.00
3/26/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight$4.00 ➝ $10.00
3/25/2024HC WainwrightReiterated RatingBuy ➝ Buy$15.00
1/18/2024HC WainwrightBoost Price TargetBuy ➝ Buy$5.00 ➝ $15.00
 

Top "Sleeping Giant" Crypto In The Market Now (Ad)

Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.

Click here to discover our #1 crypto pick before it's too late